6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Renal Function and Renal Platinum Content in Uninephrectomized Rats Following Cisplatin Administration

, , &
Pages 157-162 | Published online: 07 Jul 2009

References

  • Gottlieb J. A., Drewinko B. Review of the current clinical status of platinum coordination complexes in cancer chemotherapy. Can-cer Chemother Rep 1975; 59: 621–628
  • Ward S. M., Fauvie KA. The nephrotoxic effects of cis-diamminedichloroplatinum(II) (NSC-119875) in male F344 rats. Toxicol AppI Pharmacol 1976; 38: 535–547
  • Litterst C. L., Torres I. J., Guarino AM. Plasma levels and organ distribution of platinum in the rat, dog and dogfish following intravenous administration of cis-DDP(II). J Clin Hematol Oncol 1977; 7: 169–177
  • Safirstein R., Winston J., Moel D., et al. Cisplatin nephrotoxicity: Insight into mechanism. Int J Androl 1987; 10: 325–346
  • Natochin YuV, Reznik L. V., Bakchteeva V. T., et al. Cisplatin: Nephrotoxic action in vertebrates and its prevention. Comp Bio-chem Physiol 1989; 94C: 115–120
  • Reznik L. V., Myazina E. M., Shakchmatova E. I., et al. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. Br J Cancer 1991; 63: 234–236
  • Heyman S. N., Rosen S., Silva P., et al. Protective action of glycine in cisplatin nephrotoxicity. Kidney Int 1991; 40: 273–279
  • Prestayko AW. Cisplatin: A preclinical overview (pp. 457–472). Cisplatin: Current Status and New Developments., A.W Prestayko, S.T Crooke, SK Carter. Academic Press, New York 1980
  • Fine LG. The biology of renal hypertrophy. Kidney Int 1986; 29: 619–634
  • Threlfall G., Taylor D. M., Wuck AT. Studies of the changes in growth and DNA synthesis in the rat kidney during experimentally induced renal hypertrophy. Am J Pathol 1967; 50: 1–14
  • Safirstein R., Miller P., Guttenplan JB. Uptake and metabolism of cisplatin by the rat kidney. Kidney Int 1984; 25: 753–758
  • Lecointe R., Macquet J-P, Wutour J-L. Correlation between the toxicity of platinum drugs to L 1210 leucemia cells and their mu-tagenic properties. Biochem Biophys Res Commun 1979; 90: 209–213
  • Safirstein R. Renal vessels and tubule pressure and flows in the initial phase of cis-diammine dichloroplatinum nephrotoxicity. Kidney Int 1981; 19: 213
  • Gillum D. M., Truong L., Tosby J., Suki WN. Effects of uninephrec-tomy and high protein feeding in cyclosporine nephropathy. Kidney Int 1989; 36: 194–200
  • Finn W. F., Fernandez-Repollet E., Gitelman EJ. The use of nephrotoxic agents during recovery from acute renal failure. Controversies in Nephrology, G.E Schreirer, JF Winchester. Georgetown University, IY 1984; 41–52
  • Hirschberg R., Copple JD. Evidence that insulin growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 1989; 83: 326–330
  • Pera MF, Jr, Harder HC. Effects of mannitol or furosemide on cis-dichlorodiammineplatinum (II) antitumor activity and toxicity to host-renewing cell populations in rats. Cancer Res 1979; 39: 1279–1286

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.